HEADER TRANSFERASE/INHIBITOR 12-AUG-17 6AN4 TITLE CRYSTAL STRUCTURE OF ESCHERICHIA COLI HPPK IN COMPLEX WITH BISUBSTRATE TITLE 2 ANALOGUE INHIBITOR HP-39 (J1F) COMPND MOL_ID: 1; COMPND 2 MOLECULE: 2-AMINO-4-HYDROXY-6-HYDROXYMETHYLDIHYDROPTERIDINE COMPND 3 PYROPHOSPHOKINASE; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: FULL-LENGTH; COMPND 6 SYNONYM: 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYROPHOSPHOKINASE,PPPK,7, COMPND 7 8-DIHYDRO-6-HYDROXYMETHYLPTERIN-PYROPHOSPHOKINASE,HPPK; COMPND 8 EC: 2.7.6.3; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI (STRAIN K12); SOURCE 3 ORGANISM_TAXID: 83333; SOURCE 4 STRAIN: K12; SOURCE 5 GENE: FOLK, B0142, JW0138; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21-CODONPLUS(DE3)-RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PDN2163 KEYWDS ALPHA BETA, TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR G.X.SHAW,G.SHI,X.JI REVDAT 2 30-AUG-23 6AN4 1 AUTHOR JRNL REVDAT 1 15-AUG-18 6AN4 0 JRNL AUTH X.G.SHAW,G.SHI,X.JI JRNL TITL BISUBSTRATE ANALOG INHIBITORS OF HPPK: TRANSITION STATE JRNL TITL 2 MIMETICS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH G.SHI,J.BLASZCZYK,X.JI,H.YAN REMARK 1 TITL BISUBSTRATE ANALOGUE INHIBITORS OF REMARK 1 TITL 2 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYROPHOSPHOKINASE: REMARK 1 TITL 3 SYNTHESIS AND BIOCHEMICAL AND CRYSTALLOGRAPHIC STUDIES REMARK 1 REF J. MED. CHEM. V. 44 1364 2001 REMARK 1 REFN ISSN 0022-2623 REMARK 1 REFERENCE 2 REMARK 1 AUTH G.SHI,G.SHAW,Y.-H.LIANG,P.SUBBURAMANN,Y.LI,Y.WU,H.YAN,X.JI REMARK 1 TITL BISUBSTRATE ANALOGUE INHIBITORS OF REMARK 1 TITL 2 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYROPHOSPHOKINASE: NEW REMARK 1 TITL 3 DESIGNNNNN WITH IMPROVED PROPERTIES REMARK 1 REF BIOORG. MED. CHEM. V. 20 47 2012 REMARK 1 REFN ISSN 0968-0896 REMARK 1 REFERENCE 3 REMARK 1 AUTH G.SHI,G.SHAW,Y.LI,Y.WU,H.YAN,X.JI REMARK 1 TITL BISUBSTRATE ANALOG INHIBITORS OF REMARK 1 TITL 2 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYROPHOSPHOKINASE: NEW REMARK 1 TITL 3 LEAD EXHIBITS A DISTINCT BINDING MODE REMARK 1 REF BIOORG. MED. CHEM. V. 20 4303 2012 REMARK 1 REFN ISSN 0968-0896 REMARK 1 REFERENCE 4 REMARK 1 AUTH G.SHI,G.SHAW,Y.LI,Y.WU,H.YAN,X.JI REMARK 1 TITL STRUCTURAL ENZYMOLOGY AND INHIBITION OF THE BI-FUNCTIONAL REMARK 1 TITL 2 FOLATE PATHWAY ENZYME HPPK-DHPS FROM THE BIOWARFARE AGENT REMARK 1 TITL 3 FRANCISELLA TULARENSIS REMARK 1 REF FEBS J. V. 281 4123 2014 REMARK 1 REFN ISSN 1742-464X REMARK 2 REMARK 2 RESOLUTION. 1.47 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1_2575 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.47 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.85 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.380 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.7 REMARK 3 NUMBER OF REFLECTIONS : 26578 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.210 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.690 REMARK 3 FREE R VALUE TEST SET COUNT : 980 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.8519 - 2.8114 0.97 3977 153 0.1839 0.1777 REMARK 3 2 2.8114 - 2.2317 1.00 3941 150 0.1936 0.2078 REMARK 3 3 2.2317 - 1.9497 1.00 3897 150 0.2082 0.2453 REMARK 3 4 1.9497 - 1.7715 1.00 3863 147 0.2191 0.2631 REMARK 3 5 1.7715 - 1.6445 1.00 3836 148 0.2390 0.2425 REMARK 3 6 1.6445 - 1.5475 0.92 3557 135 0.2442 0.2702 REMARK 3 7 1.5475 - 1.4700 0.66 2527 97 0.2601 0.2985 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 0.90 REMARK 3 SHRINKAGE RADIUS : 0.70 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.160 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.460 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.36 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.98 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 1421 REMARK 3 ANGLE : 0.921 1959 REMARK 3 CHIRALITY : 0.061 215 REMARK 3 PLANARITY : 0.004 258 REMARK 3 DIHEDRAL : 14.953 538 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6AN4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-AUG-17. REMARK 100 THE DEPOSITION ID IS D_1000229493. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-JUN-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX300-HS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27163 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.450 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.8 REMARK 200 DATA REDUNDANCY : 5.500 REMARK 200 R MERGE (I) : 0.04200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.50 REMARK 200 COMPLETENESS FOR SHELL (%) : 52.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.31000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MIR REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.26 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NACL, SODIUM CITRATE ETC., PH 7.0, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.88900 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 38.52150 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 24.04600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 38.52150 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.88900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 24.04600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 100 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7780 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -5.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 84 REMARK 465 LYS A 85 REMARK 465 ALA A 86 REMARK 465 GLU A 87 REMARK 465 ARG A 88 REMARK 465 TRP A 89 REMARK 465 GLY A 90 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 13 78.38 -116.48 REMARK 500 ASP A 49 30.80 -89.32 REMARK 500 LEU A 94 117.71 -169.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue J1F A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 202 DBREF 6AN4 A 1 158 UNP P26281 HPPK_ECOLI 2 159 SEQRES 1 A 158 THR VAL ALA TYR ILE ALA ILE GLY SER ASN LEU ALA SER SEQRES 2 A 158 PRO LEU GLU GLN VAL ASN ALA ALA LEU LYS ALA LEU GLY SEQRES 3 A 158 ASP ILE PRO GLU SER HIS ILE LEU THR VAL SER SER PHE SEQRES 4 A 158 TYR ARG THR PRO PRO LEU GLY PRO GLN ASP GLN PRO ASP SEQRES 5 A 158 TYR LEU ASN ALA ALA VAL ALA LEU GLU THR SER LEU ALA SEQRES 6 A 158 PRO GLU GLU LEU LEU ASN HIS THR GLN ARG ILE GLU LEU SEQRES 7 A 158 GLN GLN GLY ARG VAL ARG LYS ALA GLU ARG TRP GLY PRO SEQRES 8 A 158 ARG THR LEU ASP LEU ASP ILE MET LEU PHE GLY ASN GLU SEQRES 9 A 158 VAL ILE ASN THR GLU ARG LEU THR VAL PRO HIS TYR ASP SEQRES 10 A 158 MET LYS ASN ARG GLY PHE MET LEU TRP PRO LEU PHE GLU SEQRES 11 A 158 ILE ALA PRO GLU LEU VAL PHE PRO ASP GLY GLU MET LEU SEQRES 12 A 158 ARG GLN ILE LEU HIS THR ARG ALA PHE ASP LYS LEU ASN SEQRES 13 A 158 LYS TRP HET J1F A 201 78 HET CL A 202 1 HETNAM J1F ((2-(2-AMINO-7,7-DIMETHYL-4-OXO-3,4,7,8- HETNAM 2 J1F TETRAHYDROPTERIDINE-6-CARBOXAMIDO)-N-(2-((((2R,3S,4R, HETNAM 3 J1F 5R)-5-(6-AMINO-9H-PURIN-9-YL)-3,4- HETNAM 4 J1F DIHYDROXYTETRAHYDROFURAN-2-YL)METHYL)AMINO)-2- HETNAM 5 J1F OXOETHYL)ACETAMIDO)METHYL)PHOSPHONIC ACID HETNAM CL CHLORIDE ION HETSYN J1F 5'-{[N-(2-AMINO-7,7-DIMETHYL-4-OXO-3,4,7,8- HETSYN 2 J1F TETRAHYDROPTERIDINE-6-CARBONYL)GLYCYL-N- HETSYN 3 J1F (PHOSPHONOMETHYL)GLYCYL]AMINO}-5'-DEOXYADENOSINE FORMUL 2 J1F C24 H32 N13 O10 P FORMUL 3 CL CL 1- FORMUL 4 HOH *222(H2 O) HELIX 1 AA1 PRO A 14 ASP A 27 1 14 HELIX 2 AA2 ALA A 65 GLY A 81 1 17 HELIX 3 AA3 ASP A 117 ASN A 120 5 4 HELIX 4 AA4 ARG A 121 ALA A 132 1 12 HELIX 5 AA5 MET A 142 ALA A 151 1 10 SHEET 1 AA1 4 SER A 31 VAL A 36 0 SHEET 2 AA1 4 TYR A 53 THR A 62 -1 O ALA A 59 N LEU A 34 SHEET 3 AA1 4 VAL A 2 SER A 9 -1 N ALA A 3 O LEU A 60 SHEET 4 AA1 4 ASP A 95 PHE A 101 -1 O ASP A 97 N ALA A 6 SHEET 1 AA2 4 SER A 31 VAL A 36 0 SHEET 2 AA2 4 TYR A 53 THR A 62 -1 O ALA A 59 N LEU A 34 SHEET 3 AA2 4 TYR A 40 THR A 42 -1 N THR A 42 O TYR A 53 SHEET 4 AA2 4 ASN A 156 LYS A 157 -1 O ASN A 156 N ARG A 41 SHEET 1 AA3 2 ILE A 106 ASN A 107 0 SHEET 2 AA3 2 THR A 112 VAL A 113 -1 O VAL A 113 N ILE A 106 CISPEP 1 VAL A 113 PRO A 114 0 -2.46 SITE 1 AC1 27 THR A 42 PRO A 43 PRO A 44 LEU A 45 SITE 2 AC1 27 TYR A 53 ASN A 55 GLN A 74 GLU A 77 SITE 3 AC1 27 ARG A 82 ASP A 95 LEU A 96 ASP A 97 SITE 4 AC1 27 ILE A 98 ARG A 110 LEU A 111 THR A 112 SITE 5 AC1 27 VAL A 113 HIS A 115 TYR A 116 ARG A 121 SITE 6 AC1 27 PHE A 123 HOH A 308 HOH A 334 HOH A 367 SITE 7 AC1 27 HOH A 374 HOH A 375 HOH A 447 SITE 1 AC2 4 SER A 38 PHE A 39 ARG A 75 GLN A 79 CRYST1 43.778 48.092 77.043 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022843 0.000000 0.000000 0.00000 SCALE2 0.000000 0.020793 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012980 0.00000